Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Imaging of HER2-tumours with a site-specifically 99mTc-labelled Affibody containing a cysteinyldiglycyl chelator
Show others and affiliations
2006 (English)In: European Journal of Nuclear Medicine and Molecular Imaging, ISSN 1619-7070, E-ISSN 1619-7089, Vol. 33, p. S284-S284Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Uppsala Univ, Rudbeck Lab, Unit Biomed Radiat Sci, Uppsala, Sweden. Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden. Affibody AB, Bromma, Sweden. Univ Uppsala Hosp, Uppsala, Sweden. Minist Publ Hlth Russia, Inst Biophys, Russian Res Ctr, Moscow, Russia.: SPRINGER , 2006. Vol. 33, p. S284-S284
National Category
Basic Medicine
Identifiers
URN: urn:nbn:se:kth:diva-242408ISI: 000202967400969OAI: oai:DiVA.org:kth-242408DiVA, id: diva2:1287853
Note

QCR 20190212

Available from: 2019-02-12 Created: 2019-02-12 Last updated: 2019-02-12Bibliographically approved

Open Access in DiVA

No full text in DiVA

In the same journal
European Journal of Nuclear Medicine and Molecular Imaging
Basic Medicine

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf